title: Antimicrobial prophylaxis for infants at risk for recurrent acute otitis media.
authors.affiliation: Department of Pediatrics, Boston Medical Center, Harvard Medical School, 418 Harrison Avenue, Boston, MA 02118, USA.
authors.forename: D W
authors.initials: DW
authors.lastname: Teele
authors.forename: J O
authors.initials: JO
authors.lastname: Klein
authors.forename: B M
authors.initials: BM
authors.lastname: Word
authors.forename: B A
authors.initials: BA
authors.lastname: Rosner
authors.forename: S
authors.initials: S
authors.lastname: Starobin
authors.forename: R
authors.initials: R
authors.lastname: Earle
authors.forename: C S
authors.initials: CS
authors.lastname: Ertel
authors.forename: G
authors.initials: G
authors.lastname: Fisch
authors.forename: R
authors.initials: R
authors.lastname: Michaels
authors.forename: R
authors.initials: R
authors.lastname: Heppen
authors.forename: N P
authors.initials: NP
authors.lastname: Strause
mesh_terms: D000208:Acute Disease; D000658:Amoxicillin / Q000009:adverse effects / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000009:adverse effects; D015331:Cohort Studies; D004311:Double-Blind Method; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007223:Infant; D008297:Male; D009503:Neutropenia / Q000139:chemically induced; D010034:Otitis Media with Effusion / Q000175:diagnosis / Q000517:prevention & control*; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D013444:Sulfisoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced
chemical_list: D013444:Sulfisoxazole; D000658:Amoxicillin